Biowatch

Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.' As the government announced its intention to lower the...
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the Coalition for Epidemic Preparedness...
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis

Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis

“If you miss one tiny signal, you could lose a life (Missing one tiny signal Cost a Life).
NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

Semiconductor company NVIDIA is partnering with global pharmaceutical company Eli Lilly to establish an artificial...
BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for...
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.